Truvestments Capital LLC Ascendis Pharma A/S Transaction History
Truvestments Capital LLC
- $376 Million
- Q4 2024
A detailed history of Truvestments Capital LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Truvestments Capital LLC holds 37 shares of ASND stock, worth $6,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 37
-0.0%
Holding current value
$6,092
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.67 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$910 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$840 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$733 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$721 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.19B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...